Birdwatch Note Rating
2023-03-15 22:31:55 UTC - NOT_HELPFUL
Rated by Participant: 27C39712827E216C365B8E515730B2939E844BDF1F395F5F74DC161E6C03E9C2
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details